Skip to content
AkademScholar

Products

For developers

AkademBasesoonDeveloper API
Journal

Drugs

ISSN:
0012-6667
1
h-index
1
Citations
4
Works
0.00
2-year mean citedness

Trust signals

1 of 3 signals present

Independent positive signals — not a single “predatory/legitimate” verdict, but a converging picture.

  • DOAJ
    No data
    doaj.org
  • OAK list
    No data
    OAK
  • Valid ISSN
    Present
    ISSN

This is an information label, not an official ruling. A missing signal is not a penalty — a regional journal may simply not be in DOAJ.

Trends over time

Performance over time

Citation overview

Publications (bars) and citations (line) by year

  • Publications
  • Citations
010119902012201620251990: Publications 1, Citations 02012: Publications 1, Citations 02016: Publications 1, Citations 02025: Publications 1, Citations 1

Citation history

0119902012201620251990: Citations 02012: Citations 02016: Citations 02025: Citations 1

Publication history

0119902012201620251990: Publications 12012: Publications 12016: Publications 12025: Publications 1

h-index evolution

Cumulative h-index by year

0119902012201620251990: h-index 02012: h-index 02016: h-index 02025: h-index 1

Most-cited works

  1. Catumaxomab20121 citations
  2. Nafarelin19900 citations
  3. Olaratumab: First Global Approval20160 citations
  4. Catumaxomab: First Approval20250 citations